BioPhenyx is currently serving customers ranging from big pharma to small-scale biotech enterprises and works with partners in the clinic.
Customer has doubts as to which of several identified intracellular targets to inhibit by therapy. Which target has the major role in the disease? BioPhenyx helps to clarify.
Customer has identified an intracellular target, which may play a role in disease mechanism – however no previous method has been able to clearly verify or reject the hypothesis. BioPhenyx helps to clarify.
Customer has for years worked with a particular target that is believed to play a role in disease development and tested this from different technological angles without conclusive results. BioPhenyx helps to clarify.
Customer has a proprietary drug in development, however, has doubts regarding the target population, as determined by genetic sequence variations (genetic biomarkers). BioPhenyx helps to clarify.
Partner believes that a sub-group of patients do not receive adequate therapy based on current technologies used to stratify patients for treatment. BioPhenyx helps to clarify.